Calcium Channel Blockers

"Calcium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Descriptor ID	D002121
MeSH Number(s)	D27.505.519.562.249 D27.505.954.411.192
Concept/Terms	Calcium Channel Blockers Calcium Channel Blockers Blockers, Calcium Channel Channel Blockers, Calcium Calcium Channel Antagonists Antagonists, Calcium Channel Calcium Channel Blocking Drugs Calcium Antagonists, Exogenous Calcium Antagonists, Exogenous Antagonists, Exogenous Calcium Exogenous Calcium Inhibitors Exogenous Calcium Antagonists Exogenous Calcium Blockaders Calcium Blockaders, Exogenous Calcium Inhibitors, Exogenous

Below are MeSH descriptors whose meaning is more general than "Calcium Channel Blockers".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Membrane Transport Modulators [D27.505.519.562]
Calcium Channel Blockers [D27.505.519.562.249]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Calcium Channel Blockers [D27.505.954.411.192]

Below are MeSH descriptors whose meaning is more specific than "Calcium Channel Blockers".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Calcium Channel Blockers" by people in this website by year, and whether "Calcium Channel Blockers" was a major or minor topic of these publications.

Bar chart showing 75 publications over 26 distinct years, with a maximum of 8 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1997	1	0	1
1998	1	2	3
1999	2	2	4
2000	1	2	3
2001	5	2	7
2002	0	1	1
2003	3	4	7
2004	1	3	4
2005	0	3	3
2006	2	6	8
2007	0	4	4
2008	1	1	2
2009	1	1	2
2010	0	4	4
2011	1	1	2
2012	0	1	1
2013	2	2	4
2014	1	2	3
2015	0	1	1
2017	1	1	2
2018	1	0	1
2021	0	3	3
2022	0	1	1
2023	0	1	1
2024	0	1	1

Below are the most recent publications written about "Calcium Channel Blockers" by people in Profiles.

Berkenbush M, Sherman N, Jain N, Cosmi P. Prehospital Treatment of Atrial Fibrillation: Infusion Pump for Bolus and Infusion? Prehosp Emerg Care. 2025; 29(1):85-88.

View in: PubMed
Goel H, Carey M, Elshaikh A, Krinock M, Goyal D, Nadar SK. Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review. J Cardiovasc Pharmacol. 2023 08 01; 82(2):69-85.

View in: PubMed
Derington CG, Bress AP, Moran AE, Weintraub WS, Herrick JS, Cushman WC, Kronish IM, Stults B, Shimbo D, Muntner P, Greene T, Bates JT, Chang TI, Katz LA, Rehman SU, Roumie CL, Tamariz L, King JB. Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial. Hypertension. 2023 03; 80(3):590-597.

View in: PubMed
Martinez Manzano JM, Lo KB, Jarrett SA, Chiang B, Azmaiparashvili Z. Angioedema associated with the use of dihydropyridine calcium channel blockers-A case series. Ann Allergy Asthma Immunol. 2022 02; 128(2):228-229.

View in: PubMed
Qin L, Zhang N, Ishigami J, Miller ER, Pfister M, Moran AE, Cox E. Dyskalemia risk associated with fixed-dose anti-hypertensive medication combinations. J Hum Hypertens. 2022 11; 36(11):989-995.

View in: PubMed
Martinez Manzano JM, Lo KB, Jarrett SA, Chiang B, Quintero E, Aguilar F, Azmaiparashvili Z, Eiger G, Patarroyo-Aponte G. Risk factors associated with intubation and readmissions in patients with angioedema: A single-center experience al. / Ann Allergy Asthma Immunol 127 (2021) xxx-xxx"?>. Ann Allergy Asthma Immunol. 2021 12; 127(6):682-688.e1.

View in: PubMed
Bress AP, Dodson JA, King JB, Sauer BC, Reese T, Crook J, Radwanski P, Knippenberg K, Greene T, Nelson RE, Munger MA, Weintraub WS, LaFleur J. Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris. Am J Cardiol. 2018 12 01; 122(11):1809-1816.

View in: PubMed
Dong YH, Alcusky M, Maio V, Liu J, Liu M, Wu LC, Chang CH, Lai MS, Gagne JJ. Evidence of potential bias in a comparison of ? blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study. BMJ Open. 2017 03 31; 7(3):e012997.

View in: PubMed
Keirns J, Desai A, Kowalski D, Lademacher C, Mujais S, Parker B, Schneidkraut MJ, Townsend R, Wojtkowski T, Yamazaki T, Yen M, Kowey PR. QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization. Clin Pharmacol Ther. 2017 Jun; 101(6):782-790.

View in: PubMed
Hurd L, Kirwin SM, Boggs M, Mackenzie WG, Bober MB, Funanage VL, Duncan RL. A mutation in TRPV4 results in altered chondrocyte calcium signaling in severe metatropic dysplasia. Am J Med Genet A. 2015 Oct; 167A(10):2286-93.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement